UNSPSC 51422212: Triamcinolone acetonide sodium phosphate

This classification denotes a therapeutic glucocorticoid C24H30FO9P.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R2MZ7K74S8, chemically known as pregna-1,4-diene-3,20-dione, 9-fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone, 21-(dihydrogen phosphate), disodium salt, but more generally known as triamcinolone acetonide sodium phosphate, which bears US NIH Compound Identifier 70683053.

Most nations, for tariff and trade purposes, schedule triamcinolone acetonide sodium phosphate under HS 29372200 and SITC 54153. As of Q4 2014, TRIAMCINOLONE ACETONIDE SODIUM PHOSPHATE remains US FDA's Preferred Term for this commodity. SMILES: C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)COP(=O)([O-])[O-])CCC5=CC(=O)C=C[C@@]53C)F)O.[NA+].[NA+].

UNSPSC 51422212 Triamcinolone acetonide sodium phosphate is a Commodity code that in recent state and local procurement appears primarily connected to pharmaceutical and medical supply procurement, though the single recent opportunity on file shows a significant mismatch between the code's nominal scope and the work actually being solicited. Seminole County, Florida posted an IFB in June 2026 (IFB60459723LAS) seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually—neither of which aligns with triamcinolone acetonide sodium phosphate, a corticosteroid injection. The solicitation indicates that state and local health departments and county community health agencies do use UNSPSC pharmaceutical codes to tag medical supply procurements, though the tagging in this instance appears to reflect a cataloging or system error rather than accurate code assignment.

The Seminole County opportunity—the only recent record available under this code—required electronic bid submission through the county's e-Procurement Portal with a July 26, 2023 response deadline (note: posted date June 30, 2026 conflicts with the stated deadline of July 26, 2023, indicating a data inconsistency in the source). Vendors must comply with drug-free workplace certification, E-Verify requirements, and maintain workers' compensation and commercial general liability insurance. The contract carries a two-year initial term with one-year renewal option and includes a three-month probationary period allowing termination with or without cause. Potential FEMA funding introduces Clean Air Act and Federal Water Pollution Control Act compliance obligations. No explicit MBE, WBE, or other set-aside designations are noted. Because the posted opportunity under this code does not reflect the commodity's actual pharmaceutical scope, market activity under UNSPSC 51422212 itself remains unclear from available state and local records.